Ackermann AM, Zhang J, Heller A, Briker A, Kaestner KH (2017) High-fidelity Glucagon-CreER mouse line generated by CRISPR-Cas9 assisted gene targeting
Inhaled NAC can do this, decreasing the mucus and helping to alleviate symptoms
Rats received AlCl 3 (100 mg/kg, p.o.) for 28 days, resulting in behavioral deficits, elevated malondialdehyde (MDA), reduced superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) levels, and increased acetylcholinesterase (AChE) activity
Volume of distribution calculations from pharmacokinetic studies indicate extensive tissue distribution beyond the vascular compartment
Other Investigations: Survodutide has shown positive outcomes in metabolic dysfunction-associated steatohepatitis (MASH) trials, meeting endpoints for liver fat and fibrosis improvements, suggesting broader cardiometabolic potential